Unique Detection Method and FDA Pathway
As saliva strips, our sensor platform utilizes functionalized screen-printed electrodes (SPEs) designed to detect key biomarkers (starting with cortisol) in saliva. The sensor provides a quantitative signal that is interpreted by our proprietary algorithm and displayed in real time on a connected device.
Unlike consumer wellness devices that provide unverified or directional readings, we’re setting a higher standard through clinical validation and regulatory robustness. We are currently advancing toward FDA clearance in 2026, with our first clinical trial already underway.
Non-Invasive Technology
Designed for point-of-care use, our saliva test is stable, sensitive, and seamlessly fits into existing workflows.
At the heart of ReMinded’s innovation is the groundbreaking research of our Chief Scientific Officer, Dr. Sanjida Yeasmin, whose PhD expertise in biosensor technology is making a significant impact in the healthcare industry.
Future Applications & Impact
Our first clinical focus is cortisol detection for mental health and stress-related applications, but this is just the beginning. Our technology is designed to expand into a broad panel of hormones, inflammatory markers, and even drug detection in saliva. This unlocks applications across metabolic, reproductive, and autoimmune health, empowering millions of people worldwide to understand their health more fundamentally: in a way that is both effective and user-friendly.
Award-Winning Technology
ReMinded’s device and team has been globally recognized for its healthcare impact already: 2nd Place at the Wearable Technologies Innovation World Cup, Nordic Women in Tech Awards 2024 winner, and 1st prize in Grow with Google’s pitching competition in Helsinki for $18,000. We’ve also secured competitive non-dilutive funding, affirming our solution’s scientific and societal value.
Industry Partners
Scientific progress does not happen in isolation. At ReMinded, we embrace multidisciplinary collaboration, uniting neuroscience, biosensor technology, clinical expertise, and patient-centered design to drive lasting impact. Our team’s partnerships with leading clinical institutions, alongside our collaborations with top-tier vendors like Linxens for screen-printed electrodes and PalmSens for portable readers, ensure that the solutions we bring to market are both scientifically rigorous and deeply human-centered.
Interested In
Collaborating?
ReMinded is actively seeking partnerships in the form of clinical collaborations,
research pilots, licensing opportunities, and strategic distribution.
Please contact us to explore how we can work together
to shape the future of mental health diagnostics.